0001628280-24-005418.txt : 20240216
0001628280-24-005418.hdr.sgml : 20240216
20240216185649
ACCESSION NUMBER: 0001628280-24-005418
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240216
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pang Phillip
CENTRAL INDEX KEY: 0001787370
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39083
FILM NUMBER: 24650073
MAIL ADDRESS:
STREET 1: C/O VIR BIOTECHNOLOGY, INC.
STREET 2: 499 ILLINOIS STREET, SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vir Biotechnology, Inc.
CENTRAL INDEX KEY: 0001706431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 812730369
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 OWENS STREET
STREET 2: SUITE 900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-906-4324
MAIL ADDRESS:
STREET 1: 1800 OWENS STREET
STREET 2: SUITE 900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
wk-form4_1708127793.xml
FORM 4
X0508
4
2024-02-16
0
0001706431
Vir Biotechnology, Inc.
VIR
0001787370
Pang Phillip
C/O VIR BIOTECHNOLOGY, INC.
1800 OWENS STREET, SUITE 900
SAN FRANCISCO
CA
94158
0
1
0
0
EVP & Chief Medical Officer
1
Common Stock
2024-02-16
4
S
0
3321
10.2396
D
264679
D
Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
/s/ Sung Lee, Attorney-in-Fact
2024-02-16